$5.28 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 38 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 56.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FCEA | Buy | FOREST CITY RLTY TR INC | $480,461,000 | +15.6% | 23,054,733 | +28.3% | 9.10% | +24.2% |
| SPR | Sell | SPIRIT AEROSYSTEMS HLDGS INC | $473,353,000 | -16.2% | 8,112,309 | -36.0% | 8.97% | -10.0% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $465,985,000 | -3.6% | 3,248,869 | -20.6% | 8.83% | +3.6% |
| BIDU | Buy | BAIDU INCspon adr rep a | $364,543,000 | +2.8% | 2,217,280 | +13.9% | 6.91% | +10.4% |
| NFLX | Buy | NETFLIX INC | $326,636,000 | +71.6% | 2,638,419 | +36.6% | 6.19% | +84.3% |
| JCI | Buy | JOHNSON CTLS INTL PLC | $322,616,000 | +15.7% | 7,832,383 | +30.7% | 6.11% | +24.3% |
| ITRI | ITRON INC | $286,495,000 | +12.7% | 4,558,387 | 0.0% | 5.43% | +21.1% | |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $232,950,000 | -6.9% | 2,084,567 | +10.6% | 4.41% | 0.0% |
| JD | Buy | JD COM INCspon adr cl a | $232,908,000 | +2.7% | 9,155,191 | +5.3% | 4.41% | +10.3% |
| ZBRA | Buy | ZEBRA TECHNOLOGIES CORPcl a | $188,700,000 | +59.0% | 2,200,328 | +29.1% | 3.58% | +70.8% |
| WMB | Buy | WILLIAMS COS INC DEL | $159,383,000 | +5.9% | 5,118,285 | +4.5% | 3.02% | +13.7% |
| TMH | New | TEAM HEALTH HOLDINGS INC | $145,064,000 | – | 3,338,649 | +100.0% | 2.75% | – |
| HZNP | New | HORIZON PHARMA PLC | $130,761,000 | – | 8,081,650 | +100.0% | 2.48% | – |
| CNMD | CONMED CORP | $122,530,000 | +10.3% | 2,774,045 | 0.0% | 2.32% | +18.4% | |
| SIG | New | SIGNET JEWELERS LIMITED | $119,016,000 | – | 1,262,633 | +100.0% | 2.26% | – |
| EWJ | New | ISHARES INCmsci jpn etf new | $105,085,000 | – | 2,150,745 | +100.0% | 1.99% | – |
| IWM | Sell | ISHARES TRput | $101,218,000 | -72.3% | 750,600 | -74.5% | 1.92% | -70.3% |
| SWX | New | SOUTHWEST GAS CORP | $97,512,000 | – | 1,272,668 | +100.0% | 1.85% | – |
| Buy | NEURODERM LTD | $97,311,000 | +55.6% | 4,383,358 | +29.6% | 1.84% | +67.1% | |
| RTRX | Buy | RETROPHIN INC | $96,347,000 | +1.2% | 5,089,634 | +19.7% | 1.82% | +8.7% |
| ACOR | Buy | ACORDA THERAPEUTICS INC | $85,203,000 | -2.9% | 4,532,067 | +7.8% | 1.61% | +4.3% |
| CNX | Buy | CONSOL ENERGY INC | $80,510,000 | +197.7% | 4,416,349 | +213.6% | 1.52% | +219.7% |
| AR | Sell | ANTERO RES CORP | $74,988,000 | -13.2% | 3,170,738 | -1.1% | 1.42% | -6.8% |
| INSYQ | Sell | INSYS THERAPEUTICS INC NEW | $65,607,000 | -39.0% | 7,131,221 | -21.9% | 1.24% | -34.5% |
| LGND | New | LIGAND PHARMACEUTICALS INC | $52,883,000 | – | 520,448 | +100.0% | 1.00% | – |
| IBB | Sell | ISHARES TRput | $48,750,000 | -64.8% | 183,700 | -61.6% | 0.92% | -62.1% |
| AAAP | Buy | ADVANCED ACCELERATOR APPLICsponsored ads | $47,707,000 | +76.1% | 1,782,782 | +150.6% | 0.90% | +89.1% |
| DY | New | DYCOM INDS INC | $47,508,000 | – | 591,701 | +100.0% | 0.90% | – |
| GNRC | GENERAC HLDGS INC | $46,017,000 | +12.2% | 1,129,536 | 0.0% | 0.87% | +20.6% | |
| TRN | TRINITY INDS INC | $43,526,000 | +14.8% | 1,567,956 | 0.0% | 0.82% | +23.3% | |
| FICO | Sell | FAIR ISAAC CORP | $34,139,000 | -61.4% | 286,351 | -59.7% | 0.65% | -58.6% |
| JUNO | New | JUNO THERAPEUTICS INC | $33,529,000 | – | 1,778,724 | +100.0% | 0.64% | – |
| TSCO | Buy | TRACTOR SUPPLY CO | $29,053,000 | +458.7% | 383,238 | +396.4% | 0.55% | +497.8% |
| SLCA | U S SILICA HLDGS INC | $14,108,000 | +21.7% | 248,911 | 0.0% | 0.27% | +30.9% | |
| MYOV | New | MYOVANT SCIENCES LTD | $10,173,000 | – | 817,747 | +100.0% | 0.19% | – |
| NVLNF | New | NOVELION THERAPEUTICS INC | $9,851,000 | – | 1,169,912 | +100.0% | 0.19% | – |
| INTEQ | Sell | INTELSAT S A | $5,454,000 | -1.9% | 2,042,666 | -0.5% | 0.10% | +5.1% |
| PSEC | PROSPECT CAPITAL CORPORATION | $870,000 | +3.1% | 104,194 | 0.0% | 0.02% | +6.7% | |
| AMSC | Exit | AMERICAN SUPERCONDUCTOR CORP | $0 | – | -19,610 | -100.0% | -0.00% | – |
| MNKD | Exit | MANNKIND CORP | $0 | – | -4,914,641 | -100.0% | -0.05% | – |
| WAB | Exit | WABTEC CORP | $0 | – | -120,648 | -100.0% | -0.17% | – |
| GBX | Exit | GREENBRIER COS INC | $0 | – | -285,846 | -100.0% | -0.18% | – |
| FOSL | Exit | FOSSIL GROUP INC | $0 | – | -395,925 | -100.0% | -0.19% | – |
| AEGR | Exit | AEGERION PHARMACEUTICALS INC | $0 | – | -5,703,587 | -100.0% | -0.30% | – |
| BA | Exit | BOEING CO | $0 | – | -304,927 | -100.0% | -0.71% | – |
| NFLX | Exit | NETFLIX INCcall | $0 | – | -500,000 | -100.0% | -0.87% | – |
| MYGN | Exit | MYRIAD GENETICS INC | $0 | – | -3,659,647 | -100.0% | -1.33% | – |
| DST | Exit | DST SYS INC DEL | $0 | – | -951,411 | -100.0% | -1.98% | – |
| SERV | Exit | SERVICEMASTER GLOBAL HLDGS I | $0 | – | -3,436,713 | -100.0% | -2.04% | – |
| PRGO | Exit | PERRIGO CO PLC | $0 | – | -3,022,503 | -100.0% | -4.92% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -1,661,000 | -100.0% | -6.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
| ISHARES TR | 28 | Q3 2023 | 10.9% |
| MANNKIND CORP | 24 | Q3 2023 | 0.5% |
| BAIDU INC | 21 | Q2 2018 | 8.6% |
| ITRON INC | 21 | Q3 2020 | 12.1% |
| RETROPHIN INC | 20 | Q3 2020 | 4.5% |
| HARMONIC INC | 19 | Q3 2023 | 10.5% |
| JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
| ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
| Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
| Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
| Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
| ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
| ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
| ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
| Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
| GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D | 2024-04-26 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D/A | 2024-01-22 |
| 13F-HR/A | 2023-11-14 |
| 13F-HR | 2023-11-14 |
| SC 13D | 2023-09-21 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13D/A | 2023-04-12 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.